Corteva is set to soar

Article Excerpt

CORTEVA INC., $42.97, is a buy. The company (New York symbol CTVA; TSINetwork Rating: Extra Risk) (www.corteva.com; Shares o/s: 734.2 million; Market cap: $31.0 billion; Dividend yield: 1.3%) is a leading developer of new seeds and crop chemicals including herbicides and insecticides, for the agriculture industry. In the quarter ended June 30, 2021, revenue rose 8.4%, to $5.63 billion from $5.19 billion a year earlier. The company earned $1.40 a share in the quarter. That was up 11.1% from $1.26. Corteva’s outlook remains positive, along with its industry fundamentals. Those bright prospects are supported by rising long-term demand for agricultural products. Farmers will continue to seek improved crop quality and higher yields, which ought to increase demand in Corteva’s seed and crop protection markets. Efforts by the company to develop new offerings, as well as measures to further control operating expenses, should pay off. Corteva is a buy. buy…